Wells Fargo
TERN

Wells Fargo’s Terns Pharmaceuticals TERN Stock Holding History

Wells Fargo’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.19M Sell
79,557
-16,751
-17% -$688K ﹤0.01% 2741
2025
Q4 		$3.89M Buy
96,308
+40,716
+73% +$941K ﹤0.01% 2911
2025
Q3 		$417K Buy
55,592
+9,041
+19% +$57.7K ﹤0.01% 4428
2025
Q2 		$174K Buy
46,551
+4,662
+11% +$14.6K ﹤0.01% 4852
2025
Q1 		$116K Buy
41,889
+923
+2% +$3.77K ﹤0.01% 5034
2024
Q4 		$227K Buy
40,966
+14,846
+57% +$101K ﹤0.01% 4725
2024
Q3 		$218K Buy
26,120
+1,039
+4% +$8.55K ﹤0.01% 4512
2024
Q2 		$171K Buy
25,081
+11,024
+78% +$66.8K ﹤0.01% 4620
2024
Q1 		$92.2K Buy
14,057
+2,003
+17% +$13.1K ﹤0.01% 4940
2023
Q4 		$78.2K Buy
12,054
+2,568
+27% +$13.6K ﹤0.01% 5052
2023
Q3 		$47.7K Sell
9,486
-7,827
-45% -$49.7K ﹤0.01% 5203
2023
Q2 		$151K Buy
17,313
+17,104
+8,184% +$199K ﹤0.01% 4761
2023
Q1 		$2.48K Buy
209
+83
+66% +$793 ﹤0.01% 6193
2022
Q4 		$1.28K Buy
126
+4
+3% +$27 ﹤0.01% 6112
2022
Q3 		$1K Buy
122
+70
+135% +$260 ﹤0.01% 6472
2022
Q2 		$0 Sell
52
-561
-92% -$1.12K ﹤0.01% 7478
2022
Q1 		$2K Sell
613
-4,866
-89% -$20.8K ﹤0.01% 6703
2021
Q4 		$39K Buy
5,479
+5,464
+36,427% +$45.5K ﹤0.01% 6084
2021
Q3 		$0 Buy
+15
New +$156 ﹤0.01% 7512
2021
Q2 		– Sell
-2,714
Closed -$60K – 7430
2021
Q1 		$60K Buy
+2,714
New +$59.5K ﹤0.01% 5735

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Wells Fargo's TERN Position: Q1 2026 in Review

Wells Fargo reduced its Terns Pharmaceuticals (TERN) stake by 17% in Q1 2026, selling an estimated $688K and leaving 79,557 shares worth $4.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2741.

Wells Fargo first reported a position in TERN in Q1 2021 and has held it in 20 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Wells Fargo held 79,557 shares of Terns Pharmaceuticals worth $4.19M as of Q1 2026.
  • Wells Fargo sold 16,751 Terns Pharmaceuticals shares in Q1 2026, an estimated $688K.
  • Terns Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2741 holding.
  • Wells Fargo first reported a position in Terns Pharmaceuticals in Q1 2021 and has held it in 20 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.